Towards a More Standardized Approach to Pathologic Reporting of Pancreatoduodenectomy Specimens for Pancreatic Ductal Adenocarcinoma: Cross-continental and Cross-specialty Survey From the Pancreatobiliary Pathology Society Grossing Working Group
In conclusion, this survey raises the awareness of the discordances and serves as a starting point towards further standardization of the pancreatoduodenectomy grossing and reporting protocols.
Conditions: Celiac Disease; Celiac Disease in Children; Transition of Care; Follow-up; Diet, Gluten-Free Intervention: Other: CeliCAT form Sponsor: Tampere University Hospital Not yet recruiting
Conditions: Anxiety; Pancreatic Cancer Interventions: Drug: Ketamine; Drug: Placebo Sponsor: Cedars-Sinai Medical Center Not yet recruiting
Conditions: Advanced HER2 Negative Breast Carcinoma; HRD+Breast Cancer Interventions: Drug: fluzoparib+chidamide; Drug: fluzoparib+camrelizumab Sponsor: Tianjin Medical University Cancer Institute and Hospital Recruiting
Conditions: Advanced Pancreatic Cancer; Solid Tumor Malignancies Intervention: Drug: ProAgio Sponsors: ProDa BioTech, LLC; National Cancer Institute (NCI) Not yet recruiting
Conditions: Locally Advanced Skin Squamous Cell Carcinoma; Resectable Skin Squamous Cell Carcinoma; Unresectable Skin Squamous Cell Carcinoma Interventions: Biological: Atezolizumab; Radiation: Stereotactic Body Radiation Therapy Sponsors: City of Hope Medical Center; National Cancer Institute (NCI) Not yet recruiting
Conclusions: Our first data demonstrate the feasibility of FAP-targeted theranostics. PTRT using Lu-177 FAP-2286 is - due to long tumor retention - a highly promising treatment option in a broad spectrum of cancers. Further follow-up of patients as well as prospective clinical studies are warranted.
GF Abstract The majority of patients with ductal pancreatic adenocarcinoma are already in a locally advanced or metastatic stage at the time of diagnosis and require palliative therapy. Interventional and operative measures are available for the restoration of biliary outflow in bile duct obstruction and the continuity of the upper intestinal lumen in duodenal or gastric outlet obstruction. In the presence of tumor-related pain, pain therapy according to the World Health Organization (WHO) scheme or a truncus coeliacus blockade, in cachexia a nutritional therapy and in thromboembolic events an anti...